Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cytek Biosciences (CTKB) Preferred Dividend Payments (2020 - 2021)

Cytek Biosciences (CTKB) has disclosed Preferred Dividend Payments for 2 consecutive years, with -$845000.0 as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Preferred Dividend Payments changed N/A year-over-year to -$845000.0, compared with a TTM value of $229000.0 through Dec 2022, up 102.07%, and an annual FY2021 reading of $3.0 million, down 81.47% over the prior year.
  • Preferred Dividend Payments was -$845000.0 for Q4 2021 at Cytek Biosciences, down from $1.1 million in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $1.1 million in Q3 2021 and bottomed at -$6.2 million in Q2 2020.